Z Laura Tabatabai1, Manon Auger, Daniel F I Kurtycz, Alice Laser, Rhona J Souers, Rodolfo Laucirica, Guliz A Barkan, Barbara A Crothers, Walid E Khalbuss. 1. From the Department of Pathology, University of California San Francisco, San Francisco (Dr Tabatabai); the Department of Pathology, McGill University Health Sciences Center, Montreal, Quebec, Canada (Dr Auger); the Department of Pathology, Wisconsin State Lab of Hygiene, Madison (Dr Kurtycz); the Department of Anatomic Pathology Services, North Shore Long Island Jewish Hospital System, New Hyde Park, New York (Dr Laser); the Department of Biostatistics, College of American Pathologists, Northfield, Illinois (Ms Souers); the Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas (Dr Laucirica); the Department of Pathology, Loyola University, Maywood, Illinois (Dr Barkan); the Department of Pathology and Area Lab Services, Walter Reed National Military Medical Center, Bethesda, Maryland (Dr Crothers); and the Department of Pathology, University of Pittsburgh Medical Center (UPMC)-Shadyside, Pittsburgh, Pennsylvania (Dr Khalbuss).
Abstract
CONTEXT: Although the cytomorphology of adenoid cystic carcinoma (ACC) has been well described, the accuracy of this diagnosis in fine-needle aspirates (FNAs) of the salivary glands has not been extensively evaluated. OBJECTIVE: To assess participants' responses in the College of American Pathologists (CAP) Nongynecologic Cytology (NGC) Program to determine the accuracy and false-negative rate of ACC cases in salivary gland FNAs. DESIGN: A retrospective review of the CAP NGC Program's cumulative data from 2000-2010 was performed for the general and the specific reference diagnosis categories for ACC in salivary gland FNAs according to preparation and participant types. RESULTS: Of 5156 responses, the overall concordance rates for both the general category of malignancy and the specific category of ACC were 63.6% (3279 of 5156) and 38.6% (1966 of 5088), respectively, with a false-negative rate of 36.4% (1877 of 5156). The most frequent false-negative responses were pleomorphic (1080) and monomorphic (526) adenoma (1614 of 5088, 31.5%), while lymphoma was the most frequent malignant misinterpretation. There was a significant statistical difference in concordance to the reference interpretation between the reader types: 39.9% (1006 of 2521) concordance rate for pathologists compared to 33.8% (503 of 1488) for cytotechnologists. However, there was no significant statistical difference for concordance to the general category or reference interpretation, based on preparation type (Papanicolaou versus modified Giemsa stained). CONCLUSIONS: In this interlaboratory comparison educational program, accurate identification of ACC has shown to be problematic, with ACC representing an important cause of false-negative responses. The most common diagnostic pitfall is distinguishing this entity from pleomorphic and monomorphic adenoma in the benign category and from lymphoma and adenocarcinoma in the malignant one.
CONTEXT: Although the cytomorphology of adenoid cystic carcinoma (ACC) has been well described, the accuracy of this diagnosis in fine-needle aspirates (FNAs) of the salivary glands has not been extensively evaluated. OBJECTIVE: To assess participants' responses in the College of American Pathologists (CAP) Nongynecologic Cytology (NGC) Program to determine the accuracy and false-negative rate of ACC cases in salivary gland FNAs. DESIGN: A retrospective review of the CAP NGC Program's cumulative data from 2000-2010 was performed for the general and the specific reference diagnosis categories for ACC in salivary gland FNAs according to preparation and participant types. RESULTS: Of 5156 responses, the overall concordance rates for both the general category of malignancy and the specific category of ACC were 63.6% (3279 of 5156) and 38.6% (1966 of 5088), respectively, with a false-negative rate of 36.4% (1877 of 5156). The most frequent false-negative responses were pleomorphic (1080) and monomorphic (526) adenoma (1614 of 5088, 31.5%), while lymphoma was the most frequent malignant misinterpretation. There was a significant statistical difference in concordance to the reference interpretation between the reader types: 39.9% (1006 of 2521) concordance rate for pathologists compared to 33.8% (503 of 1488) for cytotechnologists. However, there was no significant statistical difference for concordance to the general category or reference interpretation, based on preparation type (Papanicolaou versus modified Giemsa stained). CONCLUSIONS: In this interlaboratory comparison educational program, accurate identification of ACC has shown to be problematic, with ACC representing an important cause of false-negative responses. The most common diagnostic pitfall is distinguishing this entity from pleomorphic and monomorphic adenoma in the benign category and from lymphoma and adenocarcinoma in the malignant one.
Authors: Lucie Dostalova; David Kalfert; Alzbeta Jechova; Vladimir Koucky; Stepan Novak; Martin Kuchar; Michal Zabrodsky; Daniela Novakova Kodetova; Marie Ludvikova; Ivana Kholova; Jan Plzak Journal: Eur Arch Otorhinolaryngol Date: 2020-02-27 Impact factor: 2.503
Authors: Christopher C Griffith; Alessandra C Schmitt; Liron Pantanowitz; Sara E Monaco Journal: Cancer Cytopathol Date: 2017-08-21 Impact factor: 5.284
Authors: Katharine Julia Hurry; Dilhara Karunaratne; Suzanne Westley; Alessandra Booth; Keith C R B Ramesar; Ting Ting Zhang; Michael Williams; David C Howlett Journal: Br J Radiol Date: 2021-12-03 Impact factor: 3.039
Authors: Daniel N Johnson; Mine Onenerk; Jeffrey F Krane; Esther Diana Rossi; Zubair Baloch; Güliz Barkan; Massimo Bongiovanni; Fabiano Callegari; Sule Canberk; Glen Dixon; Andrew Field; Christopher C Griffith; Nirag Jhala; Sara Jiang; Daniel Kurtycz; Lester Layfield; Oscar Lin; Zahra Maleki; Miguel Perez-Machado; Marc Pusztaszeri; Philippe Vielh; He Wang; Matthew A Zarka; William C Faquin Journal: Cancer Cytopathol Date: 2020-04-08 Impact factor: 5.284
Authors: Daniel F I Kurtycz; Ester Diana Rossi; Zubair Baloch; Derek Pavelec; Emilio Madrigal; Philippe Vielh; William Faquin Journal: J Am Soc Cytopathol Date: 2020-02-11